» Articles » PMID: 35431449

Hyperandrogenism Correlates with Psychological Symptoms in Adolescents with Polycystic Ovary Syndrome

Overview
Specialty Pediatrics
Date 2022 Apr 18
PMID 35431449
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to analyze the depressive and anxiety states of adolescent girls with polycystic ovary syndrome (PCOS). This was a cross-sectional, multicenter, case-control study. A total of 100 participants (PCOS group, 51; control group, 49) aged 13-18 yr were included in the study. Body mass index was higher in patients with PCOS (P = 0.002). In the PCOS group, 28.5% of the patients had moderate-to-severe depressive symptoms, whereas the incidence was lower in controls (8.3%, P = 0.021). The State-Trait Anxiety Inventory (STAI)-State, STAI-Trait, and physical, psychosocial, and total Pediatric Quality of Life Inventory PedsQL scores were higher in the PCOS group, suggesting that anxiety was more common and the quality of life was worse in patients with PCOS than in healthy participants (P = 0.01, P = 0.03, P = 0.02, P = 0.046, and P = 0.047, respectively). The serum free testosterone (fT) levels were positively correlated with the depression and anxiety scores and negatively correlated with the psychosocial PedsQL scores. In conclusion, adolescent girls diagnosed with PCOS demonstrated higher depressive and anxiety symptoms and lower psychosocial quality of life scores than their healthy counterparts. A relationship was found between the fT level and all psychological measures.

Citing Articles

International evidence-based recommendations for polycystic ovary syndrome in adolescents.

Pena A, Witchel S, Boivin J, Burgert T, Ee C, Hoeger K BMC Med. 2025; 23(1):151.

PMID: 40069730 PMC: 11899933. DOI: 10.1186/s12916-025-03901-w.


Salivary testosterone is associated with feelings of senselessness and self-dislike in women with borderline personality disorder.

Kulakova E, Graumann L, Cho A, Deuter C, Wolf O, Hellmann-Regen J Eur J Psychotraumatol. 2024; 15(1):2431368.

PMID: 39621360 PMC: 11613350. DOI: 10.1080/20008066.2024.2431368.


Depression, anxiety and self-esteem in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis.

Li Y, Zhang J, Zheng X, Lu W, Guo J, Chen F Front Endocrinol (Lausanne). 2024; 15:1399580.

PMID: 39403587 PMC: 11471625. DOI: 10.3389/fendo.2024.1399580.

References
1.
Beck A, Ward C, Mendelson M, Mock J, ERBAUGH J . An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561-71. DOI: 10.1001/archpsyc.1961.01710120031004. View

2.
Sari S, Celik N, Uzun Cicek A . Body Perception, Self-Esteem, and Comorbid Psychiatric Disorders in Adolescents Diagnosed with Polycystic Ovary Syndrome. J Pediatr Adolesc Gynecol. 2020; 33(6):691-696. DOI: 10.1016/j.jpag.2020.08.018. View

3.
Stanikova D, Luck T, Pabst A, Bae Y, Hinz A, Glaesmer H . Associations Between Anxiety, Body Mass Index, and Sex Hormones in Women. Front Psychiatry. 2019; 10:479. PMC: 6620895. DOI: 10.3389/fpsyt.2019.00479. View

4.
Livadas S, Chaskou S, Kandaraki A, Skourletos G, Economou F, Christou M . Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome. Clin Endocrinol (Oxf). 2011; 75(5):698-703. DOI: 10.1111/j.1365-2265.2011.04122.x. View

5.
Veldhuis J, Pincus S, Ropelato M, Escobar M, Barontini M . Disruption of the joint synchrony of luteinizing hormone, testosterone, and androstenedione secretion in adolescents with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001; 86(1):72-9. DOI: 10.1210/jcem.86.1.7125. View